Home › Funds › Vest Financial, LLC › WST

Vest Financial, LLC position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

Vest Financial, LLC reported holding 182,581 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q2 2026 13F filing — a position valued at US$65.5M, representing 0.69% of its reported portfolio and ranking #37 among its reported holdings. Vest Financial, LLC has disclosed WST holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)182.58K sh
Reported value held$65.55M
Portfolio Weight0.69%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vest Financial, LLC's WST position evolved

Vest Financial, LLC first disclosed a stake in WST in Q3 2023 at 60,555 shares (US$22.7M). The position peaked in Q2 2026 at 182,581 shares, worth US$65.5M. Across 12 filings, Vest Financial, LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 182,581 shares valued at US$65.5M — a reduction of -20,367 shares quarter over quarter.. Notable position changes include a 48% increase in Q1 2024 (shares fell 17% over the following quarter), a 31% increase in Q3 2024 (shares rose 9% over the following quarter), a 54% increase in Q2 2025 (shares rose 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 60.55K $22.72M New
Q4 2023 72.19K $25.42M Add
Q1 2024 106.72K $42.23M Add
Q2 2024 115.45K $38.03M Add
Q3 2024 151.22K $45.39M Add
Q4 2024 171.64K $56.22M Add
Q1 2025 158.92K $35.58M Reduce
Q2 2025 244.81K $53.57M Add
Q3 2025 196.46K $51.54M Reduce
Q4 2025 178.08K $49.00M Reduce
Q1 2026 202.95K $50.87M Add
Q2 2026 182.58K $65.55M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 35 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$865.8M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has Vest Financial, LLC held WST?

Vest Financial, LLC has disclosed WST holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Vest Financial, LLC's current position in WST?

As of Q2 2026, Vest Financial, LLC holds 182.58K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $65.55M, representing 0.69% of its reported portfolio and ranking #37.

Has Vest Financial, LLC been buying or selling WST?

In the latest 13F filing (Q2 2026), Vest Financial, LLC reduced its position in WST. The position peaked in Q2 2026 at 182.58K shares.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.